Reuters logo
3 months ago
BRIEF-Atossa Genetics receives approval from institutional review board for continuation of its fulvestrant microcatheter phase 2 study
May 9, 2017 / 12:13 PM / 3 months ago

BRIEF-Atossa Genetics receives approval from institutional review board for continuation of its fulvestrant microcatheter phase 2 study

1 Min Read

May 9 (Reuters) - Atossa Genetics Inc:

* Atossa Genetics receives approval from institutional review board for continuation of its fulvestrant microcatheter phase 2 study

* Atossa Genetics - institutional review board associated with montefiore medical center approved fulvestrant microcatheter phase 2 study Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below